14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 CSTL stock ended at $23.80. This is 2.52% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 3.63% from a day low at $23.70 to a day high of $24.56.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Castle Biosciences, Inc. prices

Date Open High Low Close Volume
May 07, 2024 $24.28 $24.56 $23.70 $23.80 318 561
May 06, 2024 $24.43 $25.15 $24.21 $24.41 428 648
May 03, 2024 $23.50 $25.91 $22.78 $24.33 839 810
May 02, 2024 $22.14 $23.19 $21.74 $22.84 286 010
May 01, 2024 $21.25 $22.56 $21.24 $22.02 246 794
Apr 30, 2024 $21.23 $21.42 $20.81 $21.09 291 973
Apr 29, 2024 $20.50 $21.65 $20.50 $21.53 202 986
Apr 26, 2024 $19.54 $20.77 $19.34 $20.34 106 964
Apr 25, 2024 $19.07 $19.70 $18.76 $19.51 177 998
Apr 24, 2024 $20.05 $20.10 $19.72 $19.86 78 531
Apr 23, 2024 $19.61 $20.67 $19.61 $20.06 187 583
Apr 22, 2024 $19.33 $19.79 $19.14 $19.61 87 899
Apr 19, 2024 $19.04 $19.35 $18.90 $19.31 118 988
Apr 18, 2024 $18.84 $19.38 $18.64 $19.20 129 646
Apr 17, 2024 $18.88 $19.34 $18.83 $18.84 100 967
Apr 16, 2024 $19.00 $19.27 $18.74 $18.94 124 729
Apr 15, 2024 $20.04 $20.04 $19.20 $19.23 99 356
Apr 12, 2024 $20.71 $20.83 $19.79 $20.06 141 864
Apr 11, 2024 $20.81 $20.98 $20.38 $20.78 75 475
Apr 10, 2024 $20.61 $20.84 $20.26 $20.43 102 714
Apr 09, 2024 $20.83 $21.58 $20.83 $21.54 121 103
Apr 08, 2024 $20.98 $21.05 $20.28 $20.86 108 346
Apr 05, 2024 $21.06 $21.23 $20.69 $20.82 150 325
Apr 04, 2024 $21.77 $21.87 $21.08 $21.24 150 539
Apr 03, 2024 $21.90 $22.16 $21.25 $21.53 168 426
Click to get the best stock tips daily for free!

About Castle Biosciences, Inc.

Castle Biosciences. Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients w... CSTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT